These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 35295967)

  • 1. The Corona Immunitas Digital Follow-Up eCohort to Monitor Impacts of the SARS-CoV-2 Pandemic in Switzerland: Study Protocol and First Results.
    Speierer A; Chocano-Bedoya PO; Anker D; Schmid A; Keidel D; Vermes T; Imboden M; Levati S; Franscella G; Corna L; Amati R; Harju E; Luedi C; Michel G; Veys-Takeuchi C; Zuppinger C; Nusslé SG; D'Acremont V; Tall I; Salberg É; Baysson H; Lorthe E; Pennacchio F; Frei A; Kaufmann M; Geigges M; West EA; Schwab N; Cullati S; Chiolero A; Kahlert C; Stringhini S; Vollrath F; Probst-Hensch N; Rodondi N; Puhan MA; von Wyl V
    Int J Public Health; 2022; 67():1604506. PubMed ID: 35295967
    [No Abstract]   [Full Text] [Related]  

  • 2. Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland.
    West EA; Anker D; Amati R; Richard A; Wisniak A; Butty A; Albanese E; Bochud M; Chiolero A; Crivelli L; Cullati S; d'Acremont V; Epure AM; Fehr J; Flahault A; Fornerod L; Frank I; Frei A; Michel G; Gonseth S; Guessous I; Imboden M; Kahlert CR; Kaufmann L; Kohler P; Mösli N; Paris D; Probst-Hensch N; Rodondi N; Stringhini S; Vermes T; Vollrath F; Puhan MA;
    Int J Public Health; 2020 Dec; 65(9):1529-1548. PubMed ID: 33098441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland.
    Baysson H; Pennachio F; Wisniak A; Zabella ME; Pullen N; Collombet P; Lorthe E; Joost S; Balavoine JF; Bachmann D; Azman A; Pittet D; Chappuis F; Kherad O; Kaiser L; Guessous I; Stringhini S;
    BMJ Open; 2022 Jan; 12(1):e055515. PubMed ID: 35105645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated With COVID-19 Non-Vaccination in Switzerland: A Nationwide Study.
    Sabatini S; Kaufmann M; Fadda M; Tancredi S; Noor N; Van Der Linden BWA; Cullati S; Frank I; Michel G; Harju E; Luedi C; Frei A; Ballouz T; Menges D; Fehr J; Kohler P; Kahlert CR; Scheu V; Ortega N; Chocano-Bedoya P; Rodondi N; Stringhini S; Baysson H; Lorthe E; Zufferey MC; Suggs LS; Albanese E; Vincentini J; Bochud M; D'Acremont V; Nusslé SG; Imboden M; Keidel D; Witzig M; Probst-Hensch N; von Wyl V
    Int J Public Health; 2023; 68():1605852. PubMed ID: 37284510
    [No Abstract]   [Full Text] [Related]  

  • 5. Trajectories of depression, anxiety and stress among adults during the COVID-19 pandemic in Southern Switzerland: the Corona Immunitas Ticino cohort study.
    Piumatti G; Levati S; Amati R; Crivelli L; Albanese E;
    Public Health; 2022 May; 206():63-69. PubMed ID: 35381519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of SARS-CoV-2 antibodies, associated factors, experiences and attitudes of nursing home and home healthcare employees in Switzerland.
    West EA; Kotoun OJ; Schori LJ; Kopp J; Kaufmann M; Rasi M; Fehr J; Puhan MA; Frei A;
    BMC Infect Dis; 2022 Mar; 22(1):259. PubMed ID: 35296242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study.
    Bruggmann P; Senn O; Frei A; Puhan MA; Fehr J; Falcato L
    Swiss Med Wkly; 2022 Jan; 152():w30122. PubMed ID: 35019254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and association of frailty with SARS-CoV-2 infection in older adults in Southern Switzerland-Findings from the Corona Immunitas Ticino Study.
    Jiang M; Corna L; Amati R; Piumatti G; Franscella G; Crivelli L; Albanese E
    BMC Geriatr; 2023 Jan; 23(1):18. PubMed ID: 36631745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of Digital Proximity App Use and SARS-CoV-2 Vaccine Uptake in Switzerland: Analysis of Two Population-Based Cohort Studies.
    Daniore P; Moser A; Höglinger M; Probst Hensch N; Imboden M; Vermes T; Keidel D; Bochud M; Ortega Herrero N; Baggio S; Chocano-Bedoya P; Rodondi N; Tancredi S; Wagner C; Cullati S; Stringhini S; Gonseth Nusslé S; Veys-Takeuchi C; Zuppinger C; Harju E; Michel G; Frank I; Kahlert CR; Albanese E; Crivelli L; Levati S; Amati R; Kaufmann M; Geigges M; Ballouz T; Frei A; Fehr J; von Wyl V
    Int J Public Health; 2023; 68():1605812. PubMed ID: 37799349
    [No Abstract]   [Full Text] [Related]  

  • 10. Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas.
    Blankenberger J; Kaufmann M; Albanese E; Amati R; Anker D; Camerini AL; Chocano-Bedoya P; Cullati S; Cusini A; Fehr J; Harju E; Kohler P; Kriemler S; Michel G; Rodondi N; Rodondi PY; Speierer A; Tancredi S; Puhan MA; Kahlert CR;
    BMC Med; 2022 Jun; 20(1):233. PubMed ID: 35725472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of the SARS-CoV-2 virus in the population of the southern Switzerland (Canton Ticino) - cohort study, results at 12 months.
    Beretta O; Casati Pagani S; Lazzaro M; Merlani G; Bouvier Gallacchi M
    Swiss Med Wkly; 2021 Dec; 151():w30116. PubMed ID: 34964622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socioeconomic Status and Adherence to Preventive Measures During the COVID-19 Pandemic in Switzerland: A Population Based Digital Cohort Analysis.
    Tancredi S; van der Linden BWA; Chiolero A; Cullati S; Imboden M; Probst-Hensch N; Keidel D; Witzig M; Dratva J; Michel G; Harju E; Frank I; Lorthe E; Baysson H; Stringhini S; Kahlert CR; Bardoczi JB; Haller ML; Chocano-Bedoya PO; Rodondi N; Amati R; Albanese E; Corna L; Crivelli L; Kaufmann M; Frei A; von Wyl V
    Int J Public Health; 2024; 69():1606861. PubMed ID: 39022447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. University population-based prospective cohort study of SARS-CoV-2 infection and immunity (SARSSURV-ULiège): a study protocol.
    Donneau AF; Guillaume M; Bours V; Dandoy M; Darcis G; Desmecht D; Diep AN; Fievez L; Garigliany MM; Gillain N; Husson E; Michel F; Moutschen M; Paridans M; Benoît P; Sabatel C; Saegerman C; Tytgat A; Gillet L; Bureau F
    BMJ Open; 2022 Jan; 12(1):e055721. PubMed ID: 35078848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early evidence of effectiveness of digital contact tracing for SARS-CoV-2 in Switzerland.
    Salathé M; Althaus C; Anderegg N; Antonioli D; Ballouz T; Bugnon E; Čapkun S; Jackson D; Kim SI; Larus J; Low N; Lueks W; Menges D; Moullet C; Payer M; Riou J; Stadler T; Troncoso C; Vayena E; von Wyl V
    Swiss Med Wkly; 2020 Dec; 150():w20457. PubMed ID: 33327003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 infection among employees working from home and on site: An occupational study in Switzerland.
    Schmid A; Anker D; Dubois J; Bureau-Franz I; Piccardi N; Colombo Mottaz S; Cullati S; Chiolero A; Rodondi PY
    Front Public Health; 2022; 10():980482. PubMed ID: 36187688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions of immunity and vaccination certificates among the general population: a nested study within a serosurvey of anti-SARS-CoV-2 antibodies (SEROCoV-POP).
    Nehme M; Stringhini S; Guessous I; SEROCoV-Pop Study Team
    Swiss Med Wkly; 2020 Nov; 150():w20398. PubMed ID: 33202421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.